FNDC5 and sarcopenia: Although the determination of irisin is currently of no clinical relevance in terms of managing hypopituitary patients, in the near future it could be clinically applicable, as it has the potential to be a marker of physical exercise, sarcopenia or adiposity in different clinical situations, including hypopituitarism.